
Stealth Biotherapeutics Announces Delay In FDA Action Date For Barth Syndrome Application
(MENAFN- PR Newswire) - FDA decision on elamipretide for the treatment of Barth syndrome delayed - - Labelling discussions underway, but no revised action date communicated by FDA - NEEDHAM, Mass., April 29, 2025 /PRNewswire/ -- Stealth …